Oddo BHF Asset Management Sas Takes $1.61 Million Position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Oddo BHF Asset Management Sas acquired a new position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 25,445 shares of the company's stock, valued at approximately $1,613,000.

A number of other hedge funds and other institutional investors have also bought and sold shares of ACHC. SG Americas Securities LLC grew its position in Acadia Healthcare by 435.6% during the 2nd quarter. SG Americas Securities LLC now owns 18,227 shares of the company's stock valued at $1,231,000 after purchasing an additional 14,824 shares during the last quarter. Blue Trust Inc. lifted its holdings in shares of Acadia Healthcare by 86.1% during the second quarter. Blue Trust Inc. now owns 536 shares of the company's stock valued at $36,000 after purchasing an additional 248 shares in the last quarter. TCW Group Inc. boosted its position in shares of Acadia Healthcare by 63.8% during the second quarter. TCW Group Inc. now owns 62,888 shares of the company's stock valued at $4,247,000 after buying an additional 24,487 shares during the last quarter. Vaughan Nelson Investment Management L.P. raised its position in Acadia Healthcare by 67.9% in the 2nd quarter. Vaughan Nelson Investment Management L.P. now owns 733,505 shares of the company's stock worth $49,541,000 after buying an additional 296,625 shares during the last quarter. Finally, Fifth Third Wealth Advisors LLC bought a new position in Acadia Healthcare during the 2nd quarter valued at about $206,000.

Acadia Healthcare Price Performance

Shares of NASDAQ ACHC traded up $0.32 during mid-day trading on Friday, hitting $40.66. 1,084,705 shares of the company's stock traded hands, compared to its average volume of 1,039,865. The company has a market capitalization of $3.78 billion, a P/E ratio of 13.33, a PEG ratio of 1.77 and a beta of 1.29. Acadia Healthcare Company, Inc. has a 1 year low of $36.50 and a 1 year high of $87.77. The company's 50-day moving average is $45.39 and its two-hundred day moving average is $61.82. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.07 and a quick ratio of 1.07.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last issued its quarterly earnings results on Wednesday, October 30th. The company reported $0.91 earnings per share for the quarter, topping analysts' consensus estimates of $0.90 by $0.01. The firm had revenue of $815.60 million during the quarter, compared to analysts' expectations of $819.42 million. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. Acadia Healthcare's quarterly revenue was up 8.7% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.91 EPS. On average, equities analysts anticipate that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current fiscal year.

Analyst Ratings Changes

A number of equities research analysts have weighed in on the stock. KeyCorp started coverage on shares of Acadia Healthcare in a research note on Friday, October 11th. They set a "sector weight" rating for the company. Deutsche Bank Aktiengesellschaft upgraded shares of Acadia Healthcare from a "hold" rating to a "buy" rating and increased their price target for the stock from $45.00 to $75.00 in a research report on Thursday. Cantor Fitzgerald reaffirmed a "neutral" rating and issued a $52.00 target price on shares of Acadia Healthcare in a report on Tuesday. Barclays decreased their price objective on Acadia Healthcare from $76.00 to $43.00 and set an "overweight" rating on the stock in a research note on Friday, November 22nd. Finally, Royal Bank of Canada reduced their target price on shares of Acadia Healthcare from $94.00 to $64.00 and set an "outperform" rating for the company in a report on Monday, November 18th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and seven have given a buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $75.44.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.